Roivant Sciences annual operating expenses
2020
2021
2022
2023
2024
2025
Roivant Sciences Operating Expenses Growth & History (ROIV)
Roivant Sciences's operating expenses was $1.29B for fiscal 2025.
View full Roivant Sciences company overviewRoivant Sciences annual operating expenses history
| Fiscal year | Period ended | Operating expenses | Change | Growth |
|---|---|---|---|---|
| 2025 | 2026-03-31 | $1.29B | $150.8M | +13.20% |
| 2024 | 2025-03-31 | $1.14B | $258.6M | +29.26% |
| 2023 | 2024-03-31 | $884.1M | −$54.2M | −5.78% |
| 2022 | 2023-03-31 | $938.3M | −$468.6M | −33.31% |
| 2021 | 2022-03-31 | $1.41B | $312.2M | +28.52% |
| 2020 | 2021-03-31 | $1.09B | — | — |
Roivant Sciences quarterly operating expenses
Q1.20
Q2.20
Q3.20
Q4.20
Q1.21
Q2.21
Q3.21
Q4.21
Q1.22
Q2.22
Q3.22
Q1.23
Q2.23
Q3.23
Q4.23
Q1.24
Q2.24
Q3.24
Q4.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
| Fiscal quarter | Period ended | Operating expenses | Change | YoY change |
|---|---|---|---|---|
| Q1 2026 | 2026-06-30 | $367.8M | $80.7M | +28.12% |
| Q4 2025 | 2026-03-31 | $357.5M | $65.0M | +22.21% |
| Q3 2025 | 2025-12-31 | $341.2M | $57.8M | +20.38% |
| Q2 2025 | 2025-09-30 | $307.8M | −$38.4M | −11.09% |
| Q1 2025 | 2025-06-30 | $287.1M | $66.5M | +30.13% |
| Q4 2024 | 2025-03-31 | $292.5M | $160.5M | +121.62% |
| Q3 2024 | 2024-12-31 | $283.4M | $46.9M | +19.82% |
| Q2 2024 | 2024-09-30 | $346.2M | $128.6M | +59.14% |
| Q1 2024 | 2024-06-30 | $220.6M | −$77.4M | −25.98% |
| Q4 2023 | 2024-03-31 | $132.0M | — | — |
| Q3 2023 | 2023-12-31 | $236.5M | −$158.6M | −40.14% |
| Q2 2023 | 2023-09-30 | $217.5M | −$75.8M | −25.83% |
| Q1 2023 | 2023-06-30 | $298.0M | $11.4M | +3.98% |
| Q3 2022 | 2022-12-31 | $395.1M | $124.8M | +46.15% |
| Q2 2022 | 2022-09-30 | $293.3M | −$405.1M | −58.01% |
| Q1 2022 | 2022-06-30 | $286.6M | $124.5M | +76.80% |
| Q4 2021 | 2022-03-31 | $276.0M | −$280.0M | −50.35% |
| Q3 2021 | 2021-12-31 | $270.4M | $5.5M | +2.09% |
| Q2 2021 | 2021-09-30 | $698.4M | $540.6M | +342.42% |
| Q1 2021 | 2021-06-30 | $162.1M | $46.1M | +39.73% |
| Q4 2020 | 2021-03-31 | $556.0M | — | — |
| Q3 2020 | 2020-12-31 | $264.8M | — | — |
| Q2 2020 | 2020-09-30 | $157.9M | — | — |
| Q1 2020 | 2020-06-30 | $116.0M | — | — |
Roivant Sciences operating expenses trends
Over the last five fiscal years, Roivant Sciences's operating expenses increased from $1.09B to $1.29B, a change of $198.9M. The latest reported quarter, Q1 2026, shows $367.8M.
About the metric
What operating expenses mean
Operating expenses are the recurring costs of running a company’s business beyond the direct costs used to calculate gross profit. They commonly include selling, general and administrative expenses, research and development, and other operating costs.
Calculation and source
SEC-reported and calculated operating expenses
TickerStat uses operating expenses reported in company SEC filings when available. When a separate total is unavailable, it calculates operating expenses as aligned gross profit minus operating income for the same fiscal period. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Roivant Sciences source filings ↗